搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Dave Coulier shares update on cancer treatment: 'The side effects have side effects'
Dave Coulier shared an update about his cancer treatment on the latest episode of his "Full House Rewind" podcast.
The Morning Journal on MSN
1 天
GoFundMe set up for North Olmsted teen battling two types of cancer
North Olmsted High School junior Hailey Martin was diagnosed with thyroid cancer and Hodgkin’s lymphoma in December. Hailey, ...
Onlymyhealth
4 天
Diagnosed with Stage 4 Hodgkin Lymphoma, Georgie Swallow Ignored Symptoms: Exploring The ...
Explore the journey of Georgie Swallow who was diagnosed with Stage 4 Hodgkin Lymphoma after ignoring symptoms Read ahead to ...
Health Digest on MSN
1 天
James Conner's Cancer Diagnosis Explained (And How He Overcame It)
In December 2015, professional football running back James Conner was diagnosed with Hodgkin lymphoma. Here's what we know ...
Rolling Out
7 天
What you should know about blood cancer
Learn the key facts about blood cancer, including symptoms, early detection, and treatment options. Knowledge could save lives.
2minutemedicine.com
2 天
Incyte: Monjuvi improves survival in patients with relapsed or refractory follicular lymphoma
The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients ...
Cure Today
1 天
The Impact of Yescarta on Long Term Quality of Life in R/R Follicular Lymphoma
Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.
Pharmaceutical Technology
12 天
Inobrodib by CellCentric for Non-Hodgkin Lymphoma: Likelihood of Approval
Inobrodib is under clinical development by CellCentric and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData, Phase II drugs for Non-Hodgkin Lymphoma have a 33% phase transition ...
Pharmaceutical Technology
12 天
Vactosertib by MedPacto for Acute Lymphoblastic Lymphoma: Likelihood of Approval
Vactosertib is under clinical development by MedPacto and currently in Phase I for Acute Lymphoblastic Lymphoma.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈